The whistleblower responsible for numerous lawsuits against custodial powerhouse BNY Mellon is Grant Wilson, a former currency trader in the bank’s Pittsburgh operation. The lawsuits stem from alleged charges that BNY Mellon provided its clients with least favorable currency rates, which allowed the bank to pocket additional exchange fees. Mr.
An article authored by Douglas K. Rosenblum, Esquire and John A. Schwab, Esquire published in the American Bar Association Criminal Justice Magazine, Fall 2011 edition.
To read the article see: https://www.falseclaimsact.com/wp-content/uploads/2013/02/fca_article.pdf
The U.S. Attorney for the Southern District of Indiana announced on October 19, 2011, that Premier Home Care, a durable medical equipment provider in Southern Indiana, had agreed to pay $600,000 to the United States and to the State of Indiana for violations of the False Claims Act. This qui tam suit was filed in 2008 by a former Premier employee who alleged that the company violated the False Claims Act by falsely certifying its compliance with state licensing requirements when it used unlicensed personnel to set up respiratory ventilation machines for patients.
On October 21, 2011, Bloomberg News reported that Abbott Laboratories, an American pharmaceutical manufacturer, would at least $1.3 billion to settle claims that the company illegally marketed its epilepsy drug, Depakote. This announcement followed one similar from Abbott on October 19, where it disclosed that it recorded a $1.5 billion charge for the third quarter to cover a potential settlement based on government investigations of allegations that it promoted its Depakote anti-seizure drug for unauthorized uses.
On October 21, 2011, the U.S. Department of Justice announced that the pharmaceutical manufacturer, Pfizer Inc., agreed to pay $14.5 million to resolve alleged violations of the False Claims Act related to Detrol, a drug marketed for a condition called overactive bladder. This agreement resulted from a whistleblower lawsuit claiming that Pfizer marketed Detrol to men with enlarged prostates and related conditions,
New York State Attorney General Eric T. Schneiderman announced last week that the state has reached a settlement with food service provider Whitsons Culinary Group for illegally overcharging school districts and other education providers. Whitsons received savings from food vendors it worked with, but did not pass on those savings to customer schools,
On October 6, 2011, federal authorities announced the settlement of a health care fraud lawsuit against the trustees of Columbia University, New York Presbyterian Hospital, and Dr. Erik Goluboff for $995,000. The settlement resolves allegations that the defendants caused Medicare to be over-billed for urological procedures and billed for urological tests that were medically unnecessary.
Last week, Oracle Corp. and Oracle America, Inc. agreed to pay $199.5 million plus interest for failing to meet their contractual obligations to the General Services Administration (GSA). The settlement resolves a lawsuit filed on behalf of the U.S. government by former Oracle employee, Paul Frascella, who will receive $40 million as his share of the recovery in the case,
On October 3, 2011, counsel for whistleblower and qui tam Plaintiff Beatrice Maitland announced the settlement of False Claims Act allegations against a subsidiary of Select Medical Corporation for suspect “Medical Director” payments made to various physicians. Specifically, Select Specialty Hospital–Columbus, Inc. agreed to pay $7.5 million to settle claims that it submitted claims to Medicare for reimbursement based on illegal referral fee agreements between certain Select Medical Corporation hospitals and physicians who were “Medical Directors” at the hospitals that amounted to kickbacks,
On Friday September 30, 2011, the U.S. Department of Justice announced that home health provider LHC Group, Inc. (“LHC”) had agreed to pay $65 million to settle a suit brought under the False Claims Act alleging that the company charged the government for visits to Medicaid, the Federal Employees Health Benefits programs,